spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

Healthcare Best-in-class syringe components for high safety and functionality

Datwyler Sealing Solutions


We are pleased to announce that Datwyler has become a strategic partner for the supply of the rubber plungers for the Retrago syringes. This is the result of intensive team work to develop the customized design of four different plungers, provide samples for trials and prepare commercial production within shortest time lines possible.

Retrago. Automatically Retractable Syringe.

Retrago is an innovative reinvention of the syringe, implementing safety mechanisms promoting infection prevention and control. After a single injection, the Retrago syringe automatically retracts the exposed needle and prevents the re-use of the syringe.



RETRAGO syringes RETRAGO works like a normal syringe. After use, the needle retracts automatically.

Retrago is the first automatically retractable syringe that features Auto Disable (AD), Re-Use Prevention (RUP), and Sharp Injury Protection (SIP) safety mechanisms in one device.

The combination of these safety features not only protects patients, but also healthcare workers, waste management workers and the community from the risk of accidental needle stick injuries (NSI) and syringe re-use, potentially saving millions of lives.

Thanks to their unique design with a hole in the center, Datwyler‘s rubber plungers make an important contribution to ensuring that safety mechanisms function perfectly at all times. The Retrago technology is protected by a number of patents owned by Italian company P&P Patents and Technologies, which is focused on developing safety engineered medical devices.

UNAIDS Health Innovation Exchange (HIEx). RETRAGO was awarded by UNAIDS as one of the TOP 20 Global Health Innovations with the potential to deliver impact for countries reaching the Sustainable Development Goals (SDGs) and was launched during the 72th World Health Assembly from 21st to 23rd May 2019 at the UN Palais des Nations (Geneva, Switzerland) in the presence of 100 Ministers of Health.

This recognition, as well as the continued support of the Health Innovation Exchange team, has dramatically reduced the time to commercialize the innovation.

Improving the lives of patients – every day with every product. We share this aspiration with our Healthcare customers. We as an industrial supplier provide our customers with the necessary applications that not only complete their products, but also make them reliable. By meeting the high expectations of the Healthcare market, we make the future possible.
phone +41 41 875 11 23
email sealing.ch@datwyler.com
web https://sealing.datwyler.com/
email Militärstrasse 7 CH-6467 Schattdorf Switzerland
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Arcis Biotechnology appointments Professor Steve Howell as Non-Executive Chairman

Daresbury, UK, 24 July 2019: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors. Steve takes over the position from Paul Foulger, who was serving as Chairman on an interim basis on behalf of the Board.
More info >>


White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

Outsourcing in Clinical Trials Europe

26-27 October 2020, Paris, France

Arena International are delighted to announce the return of Outsourcing in Clinical Trials Europe. Part of our global series of events, this flagship show will attract the leading clinical professionals from across Europe. The 10th Annual event will be hosted in Paris.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement